162
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Development of new antituberculous agents based on new drug targets and structure–activity relationship

, Phd, Professor
Pages 21-49 | Published online: 19 Dec 2007

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Katharigatta N. Venugopala, Mohammed A. Khedr, Melendhran Pillay, Susanta K. Nayak, Sandeep Chandrashekharappa, Bandar E. Aldhubiab, Sree Harsha, Mahesh Attimard & Bharti Odhav. (2019) Benzothiazole analogs as potential anti-TB agents: computational input and molecular dynamics. Journal of Biomolecular Structure and Dynamics 37:7, pages 1830-1842.
Read now
Haruaki Tomioka, Yutaka Tatano, Ko Yasumoto & Toshiaki Shimizu. (2008) Recent advances in antituberculous drug development and novel drug targets. Expert Review of Respiratory Medicine 2:4, pages 455-471.
Read now

Articles from other publishers (4)

Haruaki Tomioka, Yutaka Tatano, Toshiaki Shimizu & Chiaki Sano. (2021) Immunoadjunctive Therapy against Bacterial Infections Using Herbal Medicines Based on Th17 Cell-mediated Protective Immunity. Current Pharmaceutical Design 27:38, pages 3949-3962.
Crossref
Valeriya Velezheva, Patrick Brennan, Pavel Ivanov, Albert Kornienko, Sergey Lyubimov, Konstantin Kazarian, Boris Nikonenko, Konstantin Majorov & Alexander Apt. (2016) Synthesis and antituberculosis activity of indole–pyridine derived hydrazides, hydrazide–hydrazones, and thiosemicarbazones. Bioorganic & Medicinal Chemistry Letters 26:3, pages 978-985.
Crossref
Haruaki TOMIOKA. (2012) Prospects for the Development of New Antituberculous Drugs Based on the Drug Targets Related to Virulence Factors Interfering with Host Cytokine Networksサイトカイン・ネットワークに介入する病原因子を drug target にした抗結核薬の開発. Kansenshogaku Zasshi 86:6, pages 715-722.
Crossref
Haruaki Tomioka, Yutaka Tatano, Chiaki Sano & Toshiaki Shimizu. (2011) Development of new antituberculous drugs based on bacterial virulence factors interfering with host cytokine networks. Journal of Infection and Chemotherapy 17:3, pages 302-317.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.